ACOG vs CBIO

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 12, 2026

ACOG

52.0
AI Score
VS
ACOG Wins

CBIO

41.1
AI Score

Investment Advisor Scores

ACOG

52score
Recommendation
HOLD

CBIO

41score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric ACOG CBIO Winner
Revenue 9.63M 1.04M ACOG
Net Income -15.27M -48.12M ACOG
Net Margin -158.6% -4631.4% ACOG
Operating Income -15.85M -51.09M ACOG
ROE -28.8% -29.5% ACOG
ROA -23.7% -26.3% ACOG
Total Assets 64.52M 182.76M CBIO
Cash 41.38M 171.59M CBIO
Current Ratio 9.03 9.66 CBIO
Free Cash Flow -18.76M -28.56M ACOG

Relative Price Performance (Last 90 Days)

ACOG 1M: -1.4% · 3M: -5.8% CBIO 1M: +15.7% · 3M: -17.4%

Current Technical Phase

ACOG

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 45

RSI (14): 45.1 · Price: $8.33

CBIO

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 55

RSI (14): 54.8 · Price: $14.44

Fundamentals Snapshot

Metric ACOG CBIO
Market Cap — —
Forward P/E -13.4 -5.4
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth 2.7% 0.0%
Gross Margin 0.9% 1.0%
Operating Margin -1.7% -14.3%
EPS -1.32 -7.63
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, ACOG is currently the stronger investment candidate, winning 7 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.